Fentanyl theft at hospital in Rome, two wardens investigated

A powerful opioid called Fentanyl was stolen from the Israel Hospital in Rome, prompting an investigation into two guards who are now under suspicion. According to investigators, flaws in the security system allowed the theft of eighty vials of the drug. The incident has raised concerns over the handling and storage of controlled substances within healthcare facilities. The theft occurred between June 11 and June 23, during which time the missing vials were initially estimated to number sixty before being confirmed as eighty. The last inventory check took place on June 11, and the discrepancy was discovered by hospital pharmacy staff on June 23. The stolen Fentanyl, a potent synthetic opioid, could have serious implications if it entered illegal channels. However, initial indications suggest the drug may have been diverted for unauthorized medical procedures rather than street distribution. Investigators from the Carabineri's National Anti-Criminal Police (Nas) and the investigative unit based in Rome are focusing on determining the destination of the stolen medication. A key lead points toward illicit medical practices, including unlicensed clinics and practitioners operating outside legal frameworks. These entities might exploit such drugs for surgical purposes, where they can command high value. The possibility that someone with insider knowledge orchestrated the theft adds complexity to the case. Security lapses were identified during inspections conducted by the Ministry of Health, in collaboration with regional authorities, local health services, and law enforcement. One critical flaw was the improper storage of keys used to access the locked cabinet containing the Fentanyl. Instead of being kept inside the hospital pharmacy, the keys were stored in an adjacent room, making them accessible to anyone with entry to that area. This oversight likely contributed significantly to the ease with which the theft could occur. The inquiry, led by prosecutor Giovanni Conzo and public prosecutor Mario Dovinola, has uncovered several procedural issues. Among these are the absence of a surveillance system and inconsistencies in the management of access keys. Multiple employees had access to the cabinet’s key, raising questions about accountability and tracking. Additionally, there are suspicions that records of pharmaceutical movements may not have been properly maintained, further complicating efforts to trace the missing vials. Minister of Health Orazio Schillaci stated there is currently no evidence suggesting the substance reached the black market. Nevertheless, the incident has prompted heightened scrutiny and regulatory action. Following the discovery, the ministry issued directives aimed at strengthening controls and convening technical meetings involving anesthesiologists and hospital pharmacists. These measures aim to improve transparency and prevent similar incidents in the future. Arturo Cavaliere, president of the Society of Hospital Pharmacy (SIFO), emphasized the need for standardized protocols governing the transfer of responsibilities among staff members. He proposed implementing strict procedures that ensure continuous custody and clear documentation of duties according to shift schedules. Such reforms would enhance security and maintain full traceability of actions related to controlled medications. The ongoing investigation continues to explore all possible angles, seeking clarity on how the theft occurred and who might have benefited from it.